Aspen Aerogels
ASPN
35 hedge funds and large institutions have $34.7M invested in Aspen Aerogels in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 9 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 11
1.19% less ownership
Funds ownership: 69.06% → 67.87% (-1.2%)
20% less funds holding
Funds holding: 44 → 35 (-9)
54% less capital invested
Capital invested by funds: $75.6M → $34.7M (-$40.9M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 9
Top Buyers
Top Sellers
ASPN Hedge Fund Activity: Q4 2018 in Review
35 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Aspen Aerogels (ASPN) for Q4 2018, worth a combined $34.7M — down 54% from $75.6M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of ASPN and 0 opened new positions — a net loss of 9 holders — while 11 trimmed existing stakes and 11 added.
The largest buyer was Oaktop Capital Management II, adding an estimated $3.71M. The largest seller was Cowen Prime Advisors, cutting an estimated $2.16M.
- 35 institutional investors held Aspen Aerogels (ASPN) as of Q4 2018, down from 44 in Q3 2018.
- Funds reported $34.7M of Aspen Aerogels stock for Q4 2018, down 54% quarter-over-quarter.
- 0 funds opened new Aspen Aerogels positions in Q4 2018 and 9 closed out, a net change of -9 holders.
- The largest Aspen Aerogels buyer in Q4 2018 was Oaktop Capital Management II, an estimated $3.71M added.
- The largest Aspen Aerogels seller in Q4 2018 was Cowen Prime Advisors, an estimated $2.16M sold.
Based on aggregated 13F filings for Q4 2018.